| Exome sequencing–based screening for BRCA1/2 expected pathogenic variants among adult biobank participants K Manickam, AH Buchanan, MLB Schwartz, MLG Hallquist, JL Williams, ... JAMA Network Open 1 (5), e182140-e182140, 2018 | 197 | 2018 |
| A model for genome-first care: returning secondary genomic findings to participants and their healthcare providers in a large research cohort MLB Schwartz, CZ McCormick, AL Lazzeri, ML D’Andra, MLG Hallquist, ... The American Journal of Human Genetics 103 (3), 328-337, 2018 | 147 | 2018 |
| Clinical outcomes of a genomic screening program for actionable genetic conditions AH Buchanan, HL Kirchner, MLB Schwartz, MA Kelly, T Schmidlen, ... Genetics in Medicine 22 (11), 1874-1882, 2020 | 101 | 2020 |
| Patient-centered precision health in a learning health care system: Geisinger’s genomic medicine experience MS Williams, AH Buchanan, FD Davis, WA Faucett, MLG Hallquist, ... Health Affairs 37 (5), 757-764, 2018 | 95 | 2018 |
| Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants AH Buchanan, K Manickam, MN Meyer, JK Wagner, MLG Hallquist, ... Genetics in Medicine 20 (5), 554-558, 2018 | 57 | 2018 |
| Developing a conceptual, reproducible, rubric-based approach to consent and result disclosure for genetic testing by clinicians with minimal genetics background KE Ormond, MLG Hallquist, AH Buchanan, D Dondanville, MK Cho, ... Genetics in Medicine 21 (3), 727-735, 2019 | 46 | 2019 |
| Positive impact of genetic counseling assistants on genetic counseling efficiency, patient volume, and cost in a cancer genetics clinic MLG Hallquist, EP Tricou, MN Hallquist, JM Savatt, H Rocha, AE Evans, ... Genetics in Medicine 22 (8), 1348-1354, 2020 | 28 | 2020 |
| Uncertainty management for individuals with Lynch Syndrome: Identifying and responding to healthcare barriers G Campbell-Salome, AH Buchanan, MLG Hallquist, AK Rahm, H Rocha, ... Patient Education and Counseling 104 (2), 403-412, 2021 | 18 | 2021 |
| Application of a framework to guide genetic testing communication across clinical indications MLG Hallquist, EP Tricou, KE Ormond, JM Savatt, CR Coughlin, ... Genome Medicine 13 (1), 71, 2021 | 17 | 2021 |
| Penetrance of breast cancer susceptibility genes from the eMERGE III network X Fan, J Wynn, N Shang, C Liu, A Fedotov, MLG Hallquist, AH Buchanan, ... JNCI Cancer Spectrum 5 (4), pkab044, 2021 | 15 | 2021 |
| A RE-AIM framework analysis of DNA-based population screening: using implementation science to translate research into practice in a healthcare system LK Jones, NT Strande, EM Calvo, J Chen, G Rodriguez, CZ McCormick, ... Frontiers in Genetics 13, 883073, 2022 | 12 | 2022 |
| Defining the critical components of informed consent for genetic testing KE Ormond, MJ Borensztein, MLG Hallquist, AH Buchanan, WA Faucett, ... Journal of Personalized Medicine 11 (12), 1304, 2021 | 12 | 2021 |
| Exome sequencing-based screening for BRCA1/2 expected pathogenic variants among adult biobank participants. JAMA Netw Open. 2018; 1 (5): e182140 K Manickam, AH Buchanan, MLB Schwartz, MLG Hallquist, JL Williams, ... This reference emphasizes the potential role for expanded genetic testing in …, 2018 | 10 | 2018 |
| Genetic counseling for patients with positive genomic screening results: Considerations for when the genetic test comes first MLB Schwartz, AH Buchanan, MLG Hallquist, CM Haggerty, AC Sturm Journal of genetic counseling 30 (3), 634-644, 2021 | 9 | 2021 |
| Observational study of population genomic screening for variants associated with endocrine tumor syndromes in a large, healthcare-based cohort JM Savatt, NM Ortiz, GM Thone, WS McDonald, MA Kelly, ASF Berry, ... BMC medicine 20 (1), 205, 2022 | 6 | 2022 |
| Investigating psychological impact after receiving genetic risk results—a survey of participants in a population genomic screening program CZ McCormick, KD Yu, A Johns, G Campbell-Salome, MLG Hallquist, ... Journal of Personalized Medicine 12 (12), 1943, 2022 | 5 | 2022 |
| A model for genome-first care: returning secondary genomic findings to participants and their healthcare providers in a large research cohort MLB Schwartz, CZ McCormick, AL Lazzeri, DAM Lindbuchler, ... bioRxiv, 166975, 2017 | 4 | 2017 |
| Defining critical educational components of informed consent for genetic testing: views of US-based genetic counselors and medical geneticists MLG Hallquist, MJ Borensztein, CR Coughlin, AH Buchanan, ... European Journal of Human Genetics 31 (10), 1165-1174, 2023 | 2 | 2023 |
| Correction to: Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants AH Buchanan, K Manickam, MN Meyer, JK Wagner, MLG Hallquist, ... Genetics in Medicine 23 (12), 2470-2470, 2021 | 1 | 2021 |
| Critical components of informed consent for genetic testing: results of a delphi consensus process KE Ormond, M Borensztein, AH Buchanan, W Faucett, MLG Hallquist, ... EUROPEAN JOURNAL OF HUMAN GENETICS 28 (SUPPL 1), 50-50, 2020 | 1 | 2020 |
